Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study.

导出原文传递

翻译打印收藏纠错

作者： Kenta,Yagi ^[1] ; Akinori,Maruo ^[2] ; Shunsuke,Ishida ^[3] ; Fuka,Aizawa ^[4] ; Soichiro,Ushio ^[5] ; Satoshi,Sakaguchi ^[4] ; Makoto,Kajizono ^[5] ; Takahiro,Niimura ^[3] ; Mitsuhiro,Goda ^[6] ; Hirofumi,Hamano ^[3] ; Yuki,Izawa-Ishizawa ^[6] ; Yoshito,Zamami ^[4] ; Keisuke,Ishizawa ^[4]

作者单位： Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima, 770-8503, Japan. yagi.kenta@tokushima-u.ac.jp. ^[1] Department of Clinical Pharmacology and Therapeutics, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan. yagi.kenta@tokushima-u.ac.jp. ^[2] Department of Pharmacy, Okayama University Hospital, Okayama, Japan. ^[3] Department of Clinical Pharmacology and Therapeutics, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan. ^[4] Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan. ^[5] Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima, 770-8503, Japan. ^[6] Department of Pharmacology and Therapeutics, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan. ^[7]

关键词 Bevacizumab Cancer Proton pump inhibitor Vonoprazan

主题词人类(Humans);质子泵抑制剂(Proton Pump Inhibitors);回顾性研究(Retrospective Studies);血管内皮生长因子A(Vascular Endothelial Growth Factor A);结直肠肿瘤(Colorectal Neoplasms);治疗结果(Treatment Outcome)

DOI 10.1007/s10238-023-01008-1

PMID 36738305

发布时间 2023-10-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交